Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Engraftment and survival following non-myeloablative allogeneic peripheral blood hematopoietic cell transplantation for malignant diseases is affected by CD8(+) T-cell dose. 46th Annual Meeting of the American-Society-of-Hematology Cao, T. M., Shizuru, J. A., Wong, R. M., Sheehan, K., Laport, G. G., Stockerl-Goldstein, K. E., JOHNSTON, L. J., Stuart, M. J., Brown, J. M., GRUMET, F. C., Negrin, R. S., Lowsky, R. AMER SOC HEMATOLOGY. 2004: 56A–56A
View details for Web of Science ID 000225127500186